Inventor · disambiguated record
Anthony W. Siadak
Also filed as: SIADAK ANTHONY W
35 granted patents·11 pending applications·1,397 citations·filing 1985–2019
98Inventor score
Top patents by PatentIndex Score
46 records- 0199US9878038B2Methods of treating atopic dermatitis with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2017·Granted Jan 30, 2018·55 cites·4 claims
- 0299US9624296B2Polynucleotides encoding IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2015·Granted Apr 18, 2017·51 cites·6 claims
- 0399US7531637B2IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2006·Granted May 12, 2009·87 cites·54 claims
- 0498US10434173B2Use of IL-31 monoclonal antibodies for treating pruritusZYMOGENETICS INC·Filed 2017·Granted Oct 8, 2019·49 cites·4 claims
- 0598US9011858B2Variable region sequences of IL-31 monoclonal antibodies and methods of useZYMOGENETICS INC·Filed 2013·Granted Apr 21, 2015·62 cites·9 claims
- 0698US8466262B2Variable region sequences of IL-31 monoclonal antibodies and methods of useSIADAK ANTHONY W·Filed 2007·Granted Jun 18, 2013·106 cites·9 claims
- 0798US8017122B2Methods of using IL-31 monoclonal antibodies to reduce inflammationZYMOGENETICS INC·Filed 2009·Granted Sep 13, 2011·69 cites·18 claims
- 0897US9822177B2Method of reducing pruritus using IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2016·Granted Nov 21, 2017·14 cites·6 claims
- 0996US8101183B2Variable region sequences of IL-31 monoclonal antibodiesSIADAK ANTHONY W·Filed 2007·Granted Jan 24, 2012·38 cites·22 claims
- 1096US6051228AAntibodies against human CD40BRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 18, 2000·202 cites·17 claims
- 1195US8568723B2Method of reducing pruritis using IL-31 monoclonal antibodiesSIADAK ANTHONY W·Filed 2011·Granted Oct 29, 2013·26 cites·8 claims
- 1294US9683037B2Method of treating atopic dermatitis with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2016·Granted Jun 20, 2017·10 cites·14 claims
- 1394US9156909B2Polynucleotides encoding IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2013·Granted Oct 13, 2015·16 cites·9 claims
- 1494US6210669B1Methods and compositions for immunomodulationBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Apr 3, 2001·194 cites·9 claims
- 1593US9512219B2IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2015·Granted Dec 6, 2016·8 cites·7 claims
- 1693US7537761B2Anti-IL-22RA antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2005·Granted May 26, 2009·18 cites·19 claims
- 1792US10273297B2Use of IL-31 monoclonal antibodies for reducing pruritusZYMOGENETICS INC·Filed 2017·Granted Apr 30, 2019·5 cites·6 claims
- 1891US5876950AMonoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapyBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Mar 2, 1999·115 cites·50 claims
- 1990US6312693B1Antibodies against human CD40Filed 1999·Granted Nov 6, 2001·68 cites·26 claims
- 2089US10259868B2Methods of treating atopic dermatitis with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2017·Granted Apr 16, 2019·4 cites·8 claims
- 2188US7393684B2Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodiesZYMOGENETICS INC·Filed 2004·Granted Jul 1, 2008·25 cites·24 claims
- 2281US8124088B2Methods of treatment using anti-IL-22RA antibodiesXU WENFENG·Filed 2009·Granted Feb 28, 2012·3 cites·4 claims
- 2380US8163286B2Anti-IL-22RA antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2009·Granted Apr 24, 2012·2 cites·10 claims
- 2479US6413514B1Methods of using antibodies against human CD40BRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jul 2, 2002·35 cites·10 claims
- 2576US7871616B2Anti-IL-22RA antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2009·Granted Jan 18, 2011·1 cites·7 claims
- 2676US6372215B1Monoclonal antibodies to human CD6BRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 16, 2002·55 cites·16 claims
- 2768US2019144533A1Polynucleotides encoding il-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2019·Application pending·0 cites
- 2868US2019374637A1Use of il-31 monoclonal antibodies for treating prurigo nodularisZYMOGENETICS INC·Filed 2019·Application pending·0 cites
- 2967US2009074661A1Anti-il-22ra antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2008·Application pending·0 cites
- 3065US4834975AHuman monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their productionGENETICS CORP·Filed 1985·Granted May 30, 1989·27 cites·15 claims
- 3165US2008233115A1Anti-il-20 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2007·Application pending·0 cites
- 3263US2015037331A1Il-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2014·Application pending·0 cites
- 3362US5627067AMonoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted May 6, 1997·9 cites·9 claims
- 3461US5998172AAnti-CD6 ligand antibodiesUNIV DUKE·Filed 1996·Granted Dec 7, 1999·16 cites·3 claims
- 3561US2013315919A1Anti-il-22ra antibodiesZYMOGENETICS INC·Filed 2013·Application pending·0 cites
- 3660US2013216542A1Variable region sequences of il-31 monoclonal antibodies and methods of useSIADAK ANTHONY W·Filed 2011·Application pending·0 cites
- 3759US8907068B2Anti-IL-20 antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2008·Granted Dec 9, 2014·0 cites·9 claims
- 3859US2012207761A1Anti-il-22ra antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2012·Application pending·0 cites
- 3959US2004209330A1Anti-IL-22RA antibodies and binding partners and methods of using in inflammationFiled 2004·Application pending·0 cites
- 4058US8536309B2Methods of producing anti-IL-22RA antibodiesXU WENFENG·Filed 2012·Granted Sep 17, 2013·0 cites·5 claims
- 4158US2006134756A1Anti-IL-20 antibodies and binding partners and methods of using in inflammationXU WENFENG·Filed 2004·Application pending·0 cites
- 4254US5662905AMonoclonal antibody compositions cross-reactive and cross-protective against P. aeruginosa serotypesBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Sep 2, 1997·12 cites·8 claims
- 4354US2008219985A1Prok2 antagonists and methods of useTHOMPSON PENNY J·Filed 2006·Application pending·0 cites
- 4447US6046314ASpα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies theretoBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 4, 2000·7 cites·5 claims
- 4539US5378812AMonoclonal antibodies cross-reactive and cross-protective against P. aeruginosa serotypesBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jan 3, 1995·4 cites·6 claims
- 4637US5628996AMethod for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodiesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted May 13, 1997·4 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Anthony W. Siadak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →